Cat.#: ACPP-1218
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1174 | Synthetic Nanodisc Human CD97 Protein (AC1174) | 10 µg | inquiry |
| ACPP-1021 | Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) | 50 µg | inquiry |
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1711 | Human PEBP1 Protein (AC1711) | 10 µg | inquiry |
| ACPP-1733 | Human CRYGC Protein (AC1733) | 5 µg | inquiry |
| ACPP-1322 | TRPM8 Blocking Peptide (AC1322) | 250 µg | inquiry |
| ACPP-1758 | Human GMFB Protein (AC1758) | 2 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.